The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.
대표청구항▼
1. A compound selected from: 4-(6-(5,7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-3-(2-hydroxyethoxy)pyridin-2-yl)-N,N,3-trimethylbenzamide;4-(6-(5,7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-3-(2-(isopropylamino)ethoxy)pyridin-2-yl)-N,N,3-trimethylbenzamide;3-Chloro-4-(6-(5, 7-dimethoxy-4-oxo-3,
1. A compound selected from: 4-(6-(5,7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-3-(2-hydroxyethoxy)pyridin-2-yl)-N,N,3-trimethylbenzamide;4-(6-(5,7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-3-(2-(isopropylamino)ethoxy)pyridin-2-yl)-N,N,3-trimethylbenzamide;3-Chloro-4-(6-(5, 7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-3-(2-hydroxyethoxy)pyridin-2-yl)-N,N-dimethylbenzamide;3-Chloro-4-(6-(5,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-3-(2-(isopropylamino)ethoxy)pyridin-2-yl)-N,N-dimethylbenzamide;(S)-7-Fluoro-5-((1-methylpyrrolidin-3-yl)oxy)-2-(6-(4-(methylsulfonyl)phenyl)pyridin-2-yl)quinazolin-4(3H)-one;4-(6-(6, 8-Dimethoxy-1-oxo-1,2-dihydroisoquinolin-3-yl)pyridin-2-yl)-N, N-dimethylbenzamide;6,8-Dimethoxy-3-(6-(4-(methylsulfonyl)phenyl)pyridin-2-yl)isoquinolin-1(2H)-one;6,8-dimethoxy-3-(6-(4-(methylsulfinyl)phenyl)pyridin-2-yl)isoquinolin-1(2H)-one;2-(6-(2-(Dimethylamino)ethoxy)-4′-(methylsulfinyl)biphenyl-3-yl)-5,7-dimethoxyquinazolin-4(3H)-one;2-(6-(Azetidin-3-yloxy)-4′-(methylsulfinyl)biphenyl-3-yl)-5,7-dimethoxyquinazolin-4(3H)-one;5,7-Dimethoxy-2-(6-(1-methylazetidin-3-yloxy)-4′-(methylsulfinyl)biphenyl-3-yl)quinazolin-4(3H)-one;2-(6-(Azetidin-3-yloxy)-4′-(methylsulfinyl)-[1,1′-biphenyl]-3-yl)-7-fluoro-5-methoxyquinazolin-4(3H)-one;7-Fluoro-5-methoxy-2-(6-((1-methylazetidin-3-yl)oxy)-4′-(methylsulfinyl)-[1,1′-biphenyl]-3-yl)quinazolin-4(3H)-one;2-(6-(2-Hydroxyethoxy)-4′-(methylsulfinyl)biphenyl-3-yl)-5,7-dimethoxyquinazolin-4(3H)-one;2-(6-(2-(Isopropylamino)ethoxy)-4′-(methylsulfinyl)biphenyl-3-yl)-5,7-dimethoxyquinazolin-4(3H)-one;2′-(Azetidin-3-yloxy)-5′-(5,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-[1,1′-biphenyl]-4-carbonitrile;5′-(5,7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-2′-((1-methylazetidin-3-yl)oxy)-[1, 1′-biphenyl]-4-carbonitrile;4-(6-(5,7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)pyridin-2-yl)-N, N-dimethylbenzamide;2-(5-(2-Hydroxyethoxy)-6-phenylpyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;2-(5-(2-(Isopropylamino)ethoxy)-6-phenylpyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;4-(6-(5,7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-3-(2-hydroxyethoxy)pyridin-2-yl)-N, N-dimethylbenzamide;2-(5-(2-Hydroxyethoxy)-6-(4-(methylsulfonyl)phenyl)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;2-(5-(2-Hydroxyethoxy)-6-(4-(methylsulfonyl)phenyl)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one methanesulfonate;4-(6-(5,7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-3-(2-(isopropylamino)ethoxy)pyridin-2-yl)-N, N-dimethylbenzamide;2-(5-(2-(Isopropylamino)ethoxy)-6-(4-(methylsulfonyl)phenyl)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;2-6(4-Acetylphenyl)-5-(2-hydroxyethoxy)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;5,7-Dimethoxy-2-(6-(4-(methylsulfonyl)phenyl)-5-(2-(pyrrolidin-1-yl)ethoxy)pyridin-2-yl)quinazolin-4(3H)-one;2-(5-(2-Hydroxyethoxy)-6-(2-(methylsulfonyl)phenyl)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;5,7-Dimethoxy-2-(6-(4-(methylsulfonyl)phenyl)-5-(2-morpholinoethoxy)pyridin-2-yl)quinazolin-4(3H)-one;2-(5-(2-(Isopropylamino)ethoxy)-6-(2-(methylsulfonyl)phenyl)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;2-(5-(2-(Isopropylamino)ethoxy)-6-(3-(methylsulfonyl)phenyl)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;2-(6-(4-(Ethylsulfonyl)phenyl)-5-(2-hydroxyethoxy)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;2-(6-(4-(Ethylsulfonyl)phenyl)-5-(2-(isopropylamino)ethoxy)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;2-(5-(2-Hydroxyethoxy)-6-(3-(methylsulfonyl)phenyl)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one methanesulfonate;2-(5-(2-Hydroxyethoxy)-6-(3-(methylsulfinyl)phenyl)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;2-(5-(2-Hydroxyethoxy)-6-(4-(methylsulfinyl)phenyl)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;2-(5-(2-Hydroxyethoxy)-6-(2-methyl-4-(methylsulfonyl)phenyl)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;2-(5-(2-(Isopropylamino)ethoxy)-6-(3-(methylsulfinyl)phenyl)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;2-(5-(2-(Isopropylamino)ethoxy)-6-(4-(methylsulfinyl)phenyl)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;2-(6-(4-(Ethylsulfonyl)phenyl)-5-(2-(pyrrolidin-1-yl)ethoxy)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;2-(6-(4-(Ethylsulfonyl)phenyl)-5-(2-morpholinoethoxy)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;2-(6-(2-(Isopropylamino)ethoxy)-4′-(methylsulfonyl)-[1,1′-biphenyl]-3-yl)-5,7-dimethoxyquinazolin-4(3H)-one;2-(5-(2-(Isopropylamino)ethoxy)-6-(2-methyl-4-(methylsulfonyl)phenyl)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;2-(5-(2-(Isopropylamino)ethoxy)-6-(4-(methylsulfonyl)-2-(trifluoromethyl)phenyl)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;5,7-Dimethoxy-2-(4′-(methylsulfinyl)-[1, 1′-biphenyl]-3-yl)quinazolin-4(3H)-one;5,7-Dimethoxy-2-(4-(4-(methylsulfinyl)phenyl)thiophen-2-yl)quinazolin-4(3H)-one;5,7-Dimethoxy-2-(6-(4-(methylsulfinyl)phenyl)pyridin-2-yl)quinazolin-4(3H)-one;5,7-Dimethoxy-2-(5-methoxy-6-(4-(methylsulfinyl)phenyl)pyridin-2-yl)quinazolin-4(3H)-one;5,7-Dimethoxy-2-(3-(5-(methylsulfinyl)thiophen-2-yl)phenyl)quinazolin-4(3H)-one;5,7-Dimethoxy-2-(7-(4-(methylsulfinyl)phenyl)-1H-indol-5-yl)quinazolin-4(3H)-one;tert-Butyl (2-((6-(5,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-2-(4-(methylsulfinyl)phenyl)pyridin-3-yl)oxy)ethyl)(isopropyl)carbamate;4-(6-(5,7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-3-methoxypyridin-2-yl)-N,N,3-trimethylbenzamide:5,7-Dimethoxy-2-(6-(4-(methylsulfinyl)phenyl)-5-(2-(pyrrolidin-1-yl)ethoxy)pyridin-2-yl)quinazolin-4(3H)-one;3-Chloro-4-(6-(5,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-3-methoxypyridin-2-yl)-N, N-dimethylbenzamide;5-Methoxy-2-(5-methoxy-6-(4-(methylsulfinyl)phenyl)pyridin-2-yl)quinazolin-4(3H)-one;5,7-Dimethoxy-2-(5-methoxy-6-(4-(methylsulfonyl)phenyl)pyridin-2-yl)quinazolin-4(3H)-one;2-Chloro-5′-(5,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-2′-methoxy-N,N-dimethyl-[1, 1′-biphenyl]-4-carboxamide;2-(5-(2-Hydroxyethoxy)-6-(4-(methylsulfinyl)phenyl)pyridin-2-yl)-7-methoxyquinazolin-4(3H)-one;2-(5-(2-Hydroxyethoxy)-6-(4-(methylsulfinyl)phenyl)pyridin-2-yl)-7-methoxyquinazolin-4-(3H)-one;2-(5-(2-Hydroxyethoxy)-6-(4-(methylsulfonyl)phenyl)pyridin-2-yl)-5-methoxyquinazolin-4(3H)-one;1-(2-((6-(5,7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-2-(4-(methylsulfonyl)phenyl)pyridin-3-yl)oxy)ethyl)pyrrolidine 1-oxide;2-(5-(2-(Isopropylamino)ethoxy)-6-(4-(methylsulfonyl)phenyl)pyridin-2-Yl)-5-methoxyquinazolin-4(3H)-one;2-(5-(2-(Isopropylamino)ethoxy)-6-(4-(methylsulfinyl)phenyl)pyridin-2-yl)quinazolin-4(3H)-one;2-(5-(2-(Isopropylamino)ethoxy)-6-(4-(methylsulfinyl)phenyl)pyridin-2-yl)-7-methoxyquinazolin-4(3H)-one;2-(5-(2-Isopropylamino)ethoxy)-6-(4-(methylsulfonyl)phenyl)pyridin-2-yl)-7-methoxyquinazolin-4(3H)-one;2-(5-(2-(Isopropylamino)ethoxy)-6-(4-(methylsulfonyl)phenyl)pyridin-2-yl)quinazolin-4(3H)-one; andstereoisomers, tautomers, pharmaceutically acceptable salts, and hydrates thereof. 2. The compound according to claim 1, wherein the compound is selected from: 2-(5-(2-Hydroxyethoxy)-6-(4-(methyfsulfonyl)phenyl)pyridin-2-yl)-5,7-dimethoxyqusnazolin-4(3H)-one;2-(5-(2-Hydroxyethoxy)-6-(4-(methylsulfonyl)phenyl)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one methanesulfonate;2-(5-(2-(Isopropylamino)ethoxy)-6-(4-(methylsulfonyl)phenyl)pyridin-2-yl)-5,7-dimethoxyquinazoline-4(3H)-one;2-(5-(2-(Isopropylamino)ethoxy)-6-(4-(methylsulfinyl)phenyl)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;5,7-Dimethoxy-2-(5-methoxy-6-(4-(methylsulfinyl)phenyl)pyridin-2-yl)quinazolin-4(3H)-one; andstereoisomers, tautomers, pharmaceutically acceptable salts, and hydrates thereof. 3. A pharmaceutical composition comprising a compound according to claim 1 or claim 2. 4. A method for inhibiting BET proteins in a mammal comprising administering a therapeutically effective amount of a compound according to claim 1 or claim 2.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (73)
Sheng-Chu Kuo TW; Mann-Jen Hour TW; Li-Jiau Huang TW; Kuo-Hsiung Lee, 2-phenyl-4-quinazolinone compounds, 2-phenyl-4-alkoxy-quinazoline compounds and their pharmaceutical compositions.
Blankley Clifton John ; Doherty Annette Marian ; Hamby James Marino ; Panek Robert Lee ; Schroeder Mel Conrad ; Showalter Howard Daniel Hollis ; Connolly Cleo, 6-Aryl pyrido[2,3-d] pyrimidines and naphthyridines for inhibiting protein tyrosine kinase mediated cellular proliferat.
Klunk William E. ; Pettegrew Jay W. ; Mathis ; Jr. Chester A., Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition.
Puwen Zhang ; Reinhold H. W. Bender ; Jay E. Wrobel ; Lin Zhi ; Todd K. Jones ; James P. Edwards ; Christopher M. Tegley, Benzimidazolones and analogues.
Dressel Jrgen (Wuppertal DEX) Fey Peter (Wuppertal DEX) Hanko Rudolf H. (Dsseldorf DEX) Hbsch Walter (Wuppertal DEX) Krmer Thomas (Wuppertal DEX) Mller Ulrich E. (Wuppertal DEX) Mller-Gliemann Matthi, Biphenylmethyl-substituted pyridones.
Spada Alfred P. (Lansdale PA) Maquire Martin P. (King of Prussia PA) Persons Paul E. (King of Prussia PA) Myers Michael R. (Reading PA), Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase.
Spada Alfred P. (Lansdale PA) Myers Michael R. (Reading PA) Maguire Martin P. (Mont Clare PA) Persons Paul E. (King of Prussia PA), Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase.
Bisgaier Charles Larry ; Creger Paul Leroy ; Saltiel Alan Robert ; Tafuri Sherrie Rae, Carboxyalkylethers, formulations, and treatment of vascular diseases.
Guthrie Najla,CAX ; Kurowska Elzbieta Maria,CAX, Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols.
Stein Bernd M. ; Anderson David Wesley ; Gayo-Fung Leah M. ; Sutherland May S. ; Doubleday Mary ; Shevlin Graziella I. ; Kois Adam ; Khammungkhune Sak ; Jalluri Ravi Kumar ; Bhagwat Shripad S. ; McKi, Compounds and methods for modulation of estrogen receptors.
Magarian Robert A. (Norman OK) Pento Joseph T. (Norman OK) Avor Kwasi S. (Columbia MO), Diphenylcyclopropyl analogs as antiestrogenic and antitumor agents.
Wong, Norman C. W.; Tucker, Joseph E. L.; Hansen, Henrik C.; Chiacchia, Fabrizio S.; McCaffrey, David, Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases.
Wong, Norman C. W.; Tucker, Joseph E. L.; Hansen, Henrik C.; Chiacchia, Fabrizio S.; McCaffrey, David, Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases.
Bok Song-Hae,KRX ; Son Kwang-Hee,KRX ; Jeong Tae-Sook,KRX ; Kwon Byoung-Mog,KRX ; Kim Young-Kook,KRX ; Choi Doil,KRX ; Kim Sung-Uk,KRX ; Bae Ki-Hwan,KRX ; Park Yong-Bok,KRX ; Choi Myung-Sook,KRX ; Hw, Hesperidin and hesperetin as 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitor.
Bolland Yves (Vanves FRX) Lewin Guy (Rueil Malmaison FRX) Vilaine Jean-Paul (Chatenay Malabry FRX) Lenaers Albert (Triel sur Seine FRX) Thollon Catherine (Paris FRX), Medicinal use of 3′,5′-di-tert.-butyl-4′-hydroxy flavones.
Hansen, Henrik C.; Chopade, Shubham P.; Citineni, Janakiram R.; Short, Robert P.; Yiannikouros, George P., Methods of preparing quinazolinone derivatives.
Wong, Norman C. W.; Hansen, Henrik C.; Chiacchia, Fabrizio S.; Johansson, Jan O., Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices.
John M. Pezzuto ; Richard C. Moon ; Mei-Shiang Jang ; Aomar Ouali CA; Shengzhao Lin CA; Karla Slowing Barillas ES, Pharmaceutical formulations of resveratrol and methods of use thereof.
Wong, Norman C. W.; Tucker, Joseph E. L.; Hansen, Henrik C.; Chiacchia, Fabrizio S.; McCaffrey, David, Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases.
Wong, Norman C. W.; Tucker, Joseph E. L.; Hansen, Henrik C.; Chiacchia, Fabrizio S.; McCaffrey, David, Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases.
Schindler, Ursula; Schonafinger, Karl; Strobel, Hartmut; Schindler, Peter, Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments.
Dressel Jrgen (Wuppertal DEX) Fey Peter (Wuppertal DEX) Hanko Rudolf H. (Dsseldorf DEX) Hbsch Walter (Wuppertal DEX) Krmer Thomas (Wuppertal DEX) Mller Ulrich E. (Wuppertal DEX) Mller-Gliemann Matthi, Sulfonylbenzyl-substituted benzo- and pyridopyridones.
Rouy, Didier; Duverger, Nicolas; Emmanuel, Florence; Denefle, Patrice; Houdebine, Louis-Marie; Viglietta, Celine; Rubin, Edward M.; Hughes, Steven D., Transgenic rabbit that expresses a functional human lipoprotein (a).
※ AI-Helper는 부적절한 답변을 할 수 있습니다.